This website contains certain statements that are not historical facts and may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statement made by SynDermix AG (“the Company”). These factors include (but are not limited to):
The Company is an emerging clinical-stage healthcare company with higher investment risk and greater potential compared to larger or more established companies. If one or more of these risks or uncertainties materialises, or if underlying assumptions prove incorrect, the Company’s actual results may vary materially from those expected, estimated or projected. Given these risks and uncertainties, potential investors should not place any reliance on forward-looking statements
Without limiting the generality of the foregoing, no assurance is given as to when the Company’s products will be launched or licensed or whether that launch or licensing will be commercially successful, and words such as “may”, “will”, “to”, “expect”, “plan”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate” or “continue” or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements
Neither the Company nor its directors undertake any obligation to update forward-looking statements or risk factors other than as required by applicable law, whether as a result of new information, future events or otherwise.